IOBT - IO Biotech Inc
0.25
-0.016 -6.280%
Share volume: 3,163,303
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$0.27
-0.02
-0.06%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-12-2024 | 05-14-2025 | 11-14-2025 | |
| Assets | ||||||
| Total Assets | 128.159 M | 111.467 M | 89.945 M | 45.736 M | 39.956 M | |
| Current Assets | 124.128 M | 107.652 M | 86.244 M | 42.342 M | 36.831 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 117.982 M | 100.747 M | 80.185 M | 37.086 M | 30.664 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 788.000 K | 735.000 K | 695.000 K | 617.000 K | 544.000 K | |
| Other Assets | 3.243 M | 3.080 M | 3.006 M | 2.777 M | 2.581 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 128.159 M | 111.467 M | 89.945 M | 45.736 M | 39.956 M | |
| Total liabilities | 12.693 M | 15.195 M | 17.380 M | 19.314 M | 39.045 M | |
| Total current liabilities | 11.043 M | 13.723 M | 16.055 M | 18.286 M | 18.311 M | |
| Accounts Payable | 3.840 M | 5.016 M | 5.256 M | 5.198 M | 5.587 M | |
| Other liabilities | 1.650 M | 1.472 M | 1.325 M | 1.028 M | 4.070 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 16.664 M | |
| Other liabilities | 1.650 M | 1.472 M | 1.325 M | 1.028 M | 4.070 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 115.466 M | 96.272 M | 72.565 M | 26.422 M | 911.000 K | |
| Common stock | 408.220 M | 409.863 M | 411.545 M | 414.748 M | 424.405 M | |
| Retained earnings | -283.279 M | -303.965 M | -327.980 M | -381.734 M | -416.329 M |